Lipid-Based Nanovesicles for Simultaneous Intracellular Delivery of Hydrophobic, Hydrophilic, and Amphiphilic Species

Lipid nanovesicles (NVs) are the first nanoformulation that entered the clinical use in oncology for the treatment of solid tumors. They are indeed versatile systems which can be loaded with either hydrophobic or hydrophilic molecules, for both imaging and drug delivery, and with high biocompatibili...

Descripción completa

Detalles Bibliográficos
Autores principales: Zacheo, Antonella, Bizzarro, Luca, Blasi, Laura, Piccirillo, Clara, Cardone, Antonio, Gigli, Giuseppe, Ragusa, Andrea, Quarta, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350901/
https://www.ncbi.nlm.nih.gov/pubmed/32719782
http://dx.doi.org/10.3389/fbioe.2020.00690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350901/
https://www.ncbi.nlm.nih.gov/pubmed/32719782
http://dx.doi.org/10.3389/fbioe.2020.00690

Ejemplares similares